nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC15A2—multiple sclerosis	0.878	1	CbGaD
Ceftazidime—Ceftibuten—SLC15A2—multiple sclerosis	0.00121	0.157	CrCbGaD
Ceftazidime—Cefepime—SLC15A2—multiple sclerosis	0.000995	0.13	CrCbGaD
Ceftazidime—Cefuroxime—SLC15A2—multiple sclerosis	0.0009	0.117	CrCbGaD
Ceftazidime—Cefixime—SLC15A2—multiple sclerosis	0.000778	0.101	CrCbGaD
Ceftazidime—Cefdinir—SLC15A2—multiple sclerosis	0.000718	0.0936	CrCbGaD
Ceftazidime—Cefaclor—SLC15A2—multiple sclerosis	0.000712	0.0928	CrCbGaD
Ceftazidime—Cefotaxime—SLC15A2—multiple sclerosis	0.000563	0.0733	CrCbGaD
Ceftazidime—Ceftriaxone—SLC15A2—multiple sclerosis	0.000555	0.0723	CrCbGaD
Ceftazidime—Cefalotin—SLC15A2—multiple sclerosis	0.000486	0.0633	CrCbGaD
Ceftazidime—Cephalexin—SLC15A2—multiple sclerosis	0.000442	0.0575	CrCbGaD
Ceftazidime—Inflammation—Methotrexate—multiple sclerosis	0.000406	0.00356	CcSEcCtD
Ceftazidime—Hypotension—Cladribine—multiple sclerosis	0.000401	0.00352	CcSEcCtD
Ceftazidime—Lethargy—Dexamethasone—multiple sclerosis	0.000401	0.00352	CcSEcCtD
Ceftazidime—Lethargy—Betamethasone—multiple sclerosis	0.000401	0.00352	CcSEcCtD
Ceftazidime—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000399	0.0035	CcSEcCtD
Ceftazidime—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000397	0.00348	CcSEcCtD
Ceftazidime—Thrombophlebitis—Prednisone—multiple sclerosis	0.000395	0.00347	CcSEcCtD
Ceftazidime—Vaginal inflammation—Methotrexate—multiple sclerosis	0.000394	0.00346	CcSEcCtD
Ceftazidime—Paraesthesia—Cladribine—multiple sclerosis	0.000385	0.00338	CcSEcCtD
Ceftazidime—Leukopenia—Azathioprine—multiple sclerosis	0.000383	0.00336	CcSEcCtD
Ceftazidime—Skin exfoliation—Methotrexate—multiple sclerosis	0.000376	0.0033	CcSEcCtD
Ceftazidime—Vaginal infection—Methotrexate—multiple sclerosis	0.000372	0.00326	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00037	0.00325	CcSEcCtD
Ceftazidime—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00037	0.00325	CcSEcCtD
Ceftazidime—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000367	0.00322	CcSEcCtD
Ceftazidime—Pain—Cladribine—multiple sclerosis	0.000367	0.00322	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000361	0.00317	CcSEcCtD
Ceftazidime—Coma—Methotrexate—multiple sclerosis	0.00036	0.00316	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000351	0.00308	CcSEcCtD
Ceftazidime—Lethargy—Prednisone—multiple sclerosis	0.000349	0.00306	CcSEcCtD
Ceftazidime—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000342	0.003	CcSEcCtD
Ceftazidime—Urticaria—Cladribine—multiple sclerosis	0.000341	0.00299	CcSEcCtD
Ceftazidime—Body temperature increased—Cladribine—multiple sclerosis	0.000339	0.00298	CcSEcCtD
Ceftazidime—Abdominal pain—Cladribine—multiple sclerosis	0.000339	0.00298	CcSEcCtD
Ceftazidime—Skin disorder—Azathioprine—multiple sclerosis	0.000339	0.00297	CcSEcCtD
Ceftazidime—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000338	0.00297	CcSEcCtD
Ceftazidime—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000333	0.00292	CcSEcCtD
Ceftazidime—Infestation—Methylprednisolone—multiple sclerosis	0.000333	0.00292	CcSEcCtD
Ceftazidime—Thrombophlebitis—Methotrexate—multiple sclerosis	0.00033	0.0029	CcSEcCtD
Ceftazidime—Haemoglobin—Prednisolone—multiple sclerosis	0.000327	0.00287	CcSEcCtD
Ceftazidime—Hypotension—Azathioprine—multiple sclerosis	0.000326	0.00286	CcSEcCtD
Ceftazidime—Haemorrhage—Prednisolone—multiple sclerosis	0.000326	0.00286	CcSEcCtD
Ceftazidime—Vision blurred—Mitoxantrone—multiple sclerosis	0.000326	0.00286	CcSEcCtD
Ceftazidime—Hypersensitivity—Cladribine—multiple sclerosis	0.000316	0.00277	CcSEcCtD
Ceftazidime—Leukopenia—Mitoxantrone—multiple sclerosis	0.000309	0.00271	CcSEcCtD
Ceftazidime—Pruritus—Cladribine—multiple sclerosis	0.000303	0.00266	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000301	0.00264	CcSEcCtD
Ceftazidime—Haemoglobin—Triamcinolone—multiple sclerosis	0.000301	0.00264	CcSEcCtD
Ceftazidime—Haemoglobin—Methylprednisolone—multiple sclerosis	0.0003	0.00264	CcSEcCtD
Ceftazidime—Haemorrhage—Triamcinolone—multiple sclerosis	0.000299	0.00263	CcSEcCtD
Ceftazidime—Convulsion—Mitoxantrone—multiple sclerosis	0.000299	0.00263	CcSEcCtD
Ceftazidime—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000299	0.00262	CcSEcCtD
Ceftazidime—Hallucination—Methylprednisolone—multiple sclerosis	0.000297	0.00261	CcSEcCtD
Ceftazidime—Diarrhoea—Cladribine—multiple sclerosis	0.000294	0.00258	CcSEcCtD
Ceftazidime—Lethargy—Methotrexate—multiple sclerosis	0.000292	0.00256	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000285	0.0025	CcSEcCtD
Ceftazidime—Dizziness—Cladribine—multiple sclerosis	0.000284	0.00249	CcSEcCtD
Ceftazidime—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000282	0.00247	CcSEcCtD
Ceftazidime—Neutropenia—Prednisone—multiple sclerosis	0.000276	0.00243	CcSEcCtD
Ceftazidime—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000276	0.00242	CcSEcCtD
Ceftazidime—Abdominal pain—Azathioprine—multiple sclerosis	0.000276	0.00242	CcSEcCtD
Ceftazidime—Body temperature increased—Azathioprine—multiple sclerosis	0.000276	0.00242	CcSEcCtD
Ceftazidime—Skin disorder—Mitoxantrone—multiple sclerosis	0.000274	0.0024	CcSEcCtD
Ceftazidime—Haemoglobin—Dexamethasone—multiple sclerosis	0.000273	0.0024	CcSEcCtD
Ceftazidime—Haemoglobin—Betamethasone—multiple sclerosis	0.000273	0.0024	CcSEcCtD
Ceftazidime—Vomiting—Cladribine—multiple sclerosis	0.000273	0.00239	CcSEcCtD
Ceftazidime—Haemorrhage—Dexamethasone—multiple sclerosis	0.000272	0.00238	CcSEcCtD
Ceftazidime—Haemorrhage—Betamethasone—multiple sclerosis	0.000272	0.00238	CcSEcCtD
Ceftazidime—Angiopathy—Methylprednisolone—multiple sclerosis	0.000271	0.00238	CcSEcCtD
Ceftazidime—Rash—Cladribine—multiple sclerosis	0.00027	0.00237	CcSEcCtD
Ceftazidime—Hallucination—Betamethasone—multiple sclerosis	0.00027	0.00237	CcSEcCtD
Ceftazidime—Hallucination—Dexamethasone—multiple sclerosis	0.00027	0.00237	CcSEcCtD
Ceftazidime—Dermatitis—Cladribine—multiple sclerosis	0.00027	0.00237	CcSEcCtD
Ceftazidime—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00027	0.00237	CcSEcCtD
Ceftazidime—Headache—Cladribine—multiple sclerosis	0.000269	0.00236	CcSEcCtD
Ceftazidime—Vision blurred—Prednisolone—multiple sclerosis	0.000267	0.00234	CcSEcCtD
Ceftazidime—Hypotension—Mitoxantrone—multiple sclerosis	0.000263	0.00231	CcSEcCtD
Ceftazidime—Angioedema—Prednisolone—multiple sclerosis	0.000259	0.00227	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000257	0.00226	CcSEcCtD
Ceftazidime—Hypersensitivity—Azathioprine—multiple sclerosis	0.000257	0.00226	CcSEcCtD
Ceftazidime—Dysgeusia—Triamcinolone—multiple sclerosis	0.000255	0.00224	CcSEcCtD
Ceftazidime—Nausea—Cladribine—multiple sclerosis	0.000255	0.00224	CcSEcCtD
Ceftazidime—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000253	0.00222	CcSEcCtD
Ceftazidime—Angiopathy—Dexamethasone—multiple sclerosis	0.000246	0.00216	CcSEcCtD
Ceftazidime—Angiopathy—Betamethasone—multiple sclerosis	0.000246	0.00216	CcSEcCtD
Ceftazidime—Convulsion—Prednisolone—multiple sclerosis	0.000246	0.00216	CcSEcCtD
Ceftazidime—Eosinophilia—Methotrexate—multiple sclerosis	0.000245	0.00215	CcSEcCtD
Ceftazidime—Pain—Mitoxantrone—multiple sclerosis	0.000241	0.00212	CcSEcCtD
Ceftazidime—Diarrhoea—Azathioprine—multiple sclerosis	0.000239	0.00209	CcSEcCtD
Ceftazidime—Angioedema—Triamcinolone—multiple sclerosis	0.000238	0.00209	CcSEcCtD
Ceftazidime—Haemoglobin—Prednisone—multiple sclerosis	0.000238	0.00209	CcSEcCtD
Ceftazidime—Angioedema—Methylprednisolone—multiple sclerosis	0.000238	0.00209	CcSEcCtD
Ceftazidime—Haemorrhage—Prednisone—multiple sclerosis	0.000237	0.00208	CcSEcCtD
Ceftazidime—Hallucination—Prednisone—multiple sclerosis	0.000235	0.00207	CcSEcCtD
Ceftazidime—Pancytopenia—Methotrexate—multiple sclerosis	0.000235	0.00206	CcSEcCtD
Ceftazidime—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000231	0.00203	CcSEcCtD
Ceftazidime—Neutropenia—Methotrexate—multiple sclerosis	0.000231	0.00203	CcSEcCtD
Ceftazidime—Dizziness—Azathioprine—multiple sclerosis	0.000231	0.00202	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000231	0.00202	CcSEcCtD
Ceftazidime—Convulsion—Triamcinolone—multiple sclerosis	0.000226	0.00198	CcSEcCtD
Ceftazidime—Convulsion—Methylprednisolone—multiple sclerosis	0.000225	0.00198	CcSEcCtD
Ceftazidime—Urticaria—Mitoxantrone—multiple sclerosis	0.000224	0.00197	CcSEcCtD
Ceftazidime—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000223	0.00196	CcSEcCtD
Ceftazidime—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000223	0.00196	CcSEcCtD
Ceftazidime—Vomiting—Azathioprine—multiple sclerosis	0.000222	0.00195	CcSEcCtD
Ceftazidime—Infestation NOS—Methotrexate—multiple sclerosis	0.00022	0.00193	CcSEcCtD
Ceftazidime—Infestation—Methotrexate—multiple sclerosis	0.00022	0.00193	CcSEcCtD
Ceftazidime—Rash—Azathioprine—multiple sclerosis	0.00022	0.00193	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00022	0.00193	CcSEcCtD
Ceftazidime—Dermatitis—Azathioprine—multiple sclerosis	0.00022	0.00193	CcSEcCtD
Ceftazidime—Flushing—Prednisone—multiple sclerosis	0.00022	0.00193	CcSEcCtD
Ceftazidime—Headache—Azathioprine—multiple sclerosis	0.000219	0.00192	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000218	0.00192	CcSEcCtD
Ceftazidime—Renal failure—Methotrexate—multiple sclerosis	0.000217	0.0019	CcSEcCtD
Ceftazidime—Angioedema—Betamethasone—multiple sclerosis	0.000216	0.0019	CcSEcCtD
Ceftazidime—Angioedema—Dexamethasone—multiple sclerosis	0.000216	0.0019	CcSEcCtD
Ceftazidime—Angiopathy—Prednisone—multiple sclerosis	0.000215	0.00188	CcSEcCtD
Ceftazidime—Immune system disorder—Prednisone—multiple sclerosis	0.000214	0.00188	CcSEcCtD
Ceftazidime—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000213	0.00187	CcSEcCtD
Ceftazidime—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000212	0.00186	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000208	0.00183	CcSEcCtD
Ceftazidime—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000208	0.00183	CcSEcCtD
Ceftazidime—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000208	0.00182	CcSEcCtD
Ceftazidime—Paraesthesia—Prednisolone—multiple sclerosis	0.000208	0.00182	CcSEcCtD
Ceftazidime—Nausea—Azathioprine—multiple sclerosis	0.000207	0.00182	CcSEcCtD
Ceftazidime—Skin disorder—Methylprednisolone—multiple sclerosis	0.000206	0.00181	CcSEcCtD
Ceftazidime—Agranulocytosis—Methotrexate—multiple sclerosis	0.000206	0.0018	CcSEcCtD
Ceftazidime—Convulsion—Betamethasone—multiple sclerosis	0.000205	0.0018	CcSEcCtD
Ceftazidime—Convulsion—Dexamethasone—multiple sclerosis	0.000205	0.0018	CcSEcCtD
Ceftazidime—Haemoglobin—Methotrexate—multiple sclerosis	0.000199	0.00174	CcSEcCtD
Ceftazidime—Hypotension—Methylprednisolone—multiple sclerosis	0.000198	0.00174	CcSEcCtD
Ceftazidime—Pain—Prednisolone—multiple sclerosis	0.000198	0.00174	CcSEcCtD
Ceftazidime—Haemorrhage—Methotrexate—multiple sclerosis	0.000198	0.00174	CcSEcCtD
Ceftazidime—Vision blurred—Prednisone—multiple sclerosis	0.000194	0.0017	CcSEcCtD
Ceftazidime—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000193	0.00169	CcSEcCtD
Ceftazidime—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000193	0.00169	CcSEcCtD
Ceftazidime—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000193	0.00169	CcSEcCtD
Ceftazidime—Paraesthesia—Triamcinolone—multiple sclerosis	0.000191	0.00168	CcSEcCtD
Ceftazidime—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000191	0.00167	CcSEcCtD
Ceftazidime—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000189	0.00166	CcSEcCtD
Ceftazidime—Nervous system disorder—Betamethasone—multiple sclerosis	0.000189	0.00166	CcSEcCtD
Ceftazidime—Agitation—Prednisone—multiple sclerosis	0.000189	0.00166	CcSEcCtD
Ceftazidime—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000189	0.00166	CcSEcCtD
Ceftazidime—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000189	0.00166	CcSEcCtD
Ceftazidime—Angioedema—Prednisone—multiple sclerosis	0.000188	0.00165	CcSEcCtD
Ceftazidime—Erythema multiforme—Methotrexate—multiple sclerosis	0.000187	0.00164	CcSEcCtD
Ceftazidime—Urticaria—Prednisolone—multiple sclerosis	0.000184	0.00161	CcSEcCtD
Ceftazidime—Pain—Triamcinolone—multiple sclerosis	0.000182	0.0016	CcSEcCtD
Ceftazidime—Hypotension—Dexamethasone—multiple sclerosis	0.00018	0.00158	CcSEcCtD
Ceftazidime—Hypotension—Betamethasone—multiple sclerosis	0.00018	0.00158	CcSEcCtD
Ceftazidime—Angiopathy—Methotrexate—multiple sclerosis	0.000179	0.00157	CcSEcCtD
Ceftazidime—Vomiting—Mitoxantrone—multiple sclerosis	0.000179	0.00157	CcSEcCtD
Ceftazidime—Immune system disorder—Methotrexate—multiple sclerosis	0.000179	0.00157	CcSEcCtD
Ceftazidime—Convulsion—Prednisone—multiple sclerosis	0.000178	0.00157	CcSEcCtD
Ceftazidime—Rash—Mitoxantrone—multiple sclerosis	0.000178	0.00156	CcSEcCtD
Ceftazidime—Dermatitis—Mitoxantrone—multiple sclerosis	0.000178	0.00156	CcSEcCtD
Ceftazidime—Headache—Mitoxantrone—multiple sclerosis	0.000177	0.00155	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000174	0.00153	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000174	0.00152	CcSEcCtD
Ceftazidime—Paraesthesia—Betamethasone—multiple sclerosis	0.000173	0.00152	CcSEcCtD
Ceftazidime—Paraesthesia—Dexamethasone—multiple sclerosis	0.000173	0.00152	CcSEcCtD
Ceftazidime—Hypersensitivity—Prednisolone—multiple sclerosis	0.00017	0.0015	CcSEcCtD
Ceftazidime—Urticaria—Triamcinolone—multiple sclerosis	0.000169	0.00148	CcSEcCtD
Ceftazidime—Urticaria—Methylprednisolone—multiple sclerosis	0.000169	0.00148	CcSEcCtD
Ceftazidime—Dysgeusia—Methotrexate—multiple sclerosis	0.000169	0.00148	CcSEcCtD
Ceftazidime—Body temperature increased—Triamcinolone—multiple sclerosis	0.000168	0.00148	CcSEcCtD
Ceftazidime—Anaphylactic shock—Prednisone—multiple sclerosis	0.000168	0.00148	CcSEcCtD
Ceftazidime—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000168	0.00147	CcSEcCtD
Ceftazidime—Nausea—Mitoxantrone—multiple sclerosis	0.000167	0.00147	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000167	0.00146	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000167	0.00146	CcSEcCtD
Ceftazidime—Pain—Betamethasone—multiple sclerosis	0.000165	0.00145	CcSEcCtD
Ceftazidime—Pain—Dexamethasone—multiple sclerosis	0.000165	0.00145	CcSEcCtD
Ceftazidime—Nervous system disorder—Prednisone—multiple sclerosis	0.000165	0.00145	CcSEcCtD
Ceftazidime—Skin disorder—Prednisone—multiple sclerosis	0.000163	0.00143	CcSEcCtD
Ceftazidime—Vision blurred—Methotrexate—multiple sclerosis	0.000162	0.00142	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000158	0.00139	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000158	0.00139	CcSEcCtD
Ceftazidime—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000157	0.00138	CcSEcCtD
Ceftazidime—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000156	0.00137	CcSEcCtD
Ceftazidime—Leukopenia—Methotrexate—multiple sclerosis	0.000154	0.00135	CcSEcCtD
Ceftazidime—Urticaria—Dexamethasone—multiple sclerosis	0.000153	0.00135	CcSEcCtD
Ceftazidime—Urticaria—Betamethasone—multiple sclerosis	0.000153	0.00135	CcSEcCtD
Ceftazidime—Dizziness—Prednisolone—multiple sclerosis	0.000153	0.00134	CcSEcCtD
Ceftazidime—Body temperature increased—Dexamethasone—multiple sclerosis	0.000153	0.00134	CcSEcCtD
Ceftazidime—Abdominal pain—Betamethasone—multiple sclerosis	0.000153	0.00134	CcSEcCtD
Ceftazidime—Abdominal pain—Dexamethasone—multiple sclerosis	0.000153	0.00134	CcSEcCtD
Ceftazidime—Body temperature increased—Betamethasone—multiple sclerosis	0.000153	0.00134	CcSEcCtD
Ceftazidime—Paraesthesia—Prednisone—multiple sclerosis	0.000151	0.00132	CcSEcCtD
Ceftazidime—Pruritus—Triamcinolone—multiple sclerosis	0.000151	0.00132	CcSEcCtD
Ceftazidime—Pruritus—Methylprednisolone—multiple sclerosis	0.00015	0.00132	CcSEcCtD
Ceftazidime—Convulsion—Methotrexate—multiple sclerosis	0.000149	0.00131	CcSEcCtD
Ceftazidime—Rash—Prednisolone—multiple sclerosis	0.000146	0.00128	CcSEcCtD
Ceftazidime—Dermatitis—Prednisolone—multiple sclerosis	0.000146	0.00128	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000146	0.00128	CcSEcCtD
Ceftazidime—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000145	0.00127	CcSEcCtD
Ceftazidime—Headache—Prednisolone—multiple sclerosis	0.000145	0.00127	CcSEcCtD
Ceftazidime—Dizziness—Triamcinolone—multiple sclerosis	0.000141	0.00123	CcSEcCtD
Ceftazidime—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00014	0.00123	CcSEcCtD
Ceftazidime—Dizziness—Methylprednisolone—multiple sclerosis	0.00014	0.00123	CcSEcCtD
Ceftazidime—Nervous system disorder—Methotrexate—multiple sclerosis	0.000138	0.00121	CcSEcCtD
Ceftazidime—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000138	0.00121	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000137	0.00121	CcSEcCtD
Ceftazidime—Nausea—Prednisolone—multiple sclerosis	0.000137	0.00121	CcSEcCtD
Ceftazidime—Pruritus—Betamethasone—multiple sclerosis	0.000137	0.0012	CcSEcCtD
Ceftazidime—Pruritus—Dexamethasone—multiple sclerosis	0.000137	0.0012	CcSEcCtD
Ceftazidime—Skin disorder—Methotrexate—multiple sclerosis	0.000136	0.0012	CcSEcCtD
Ceftazidime—Vomiting—Triamcinolone—multiple sclerosis	0.000135	0.00119	CcSEcCtD
Ceftazidime—Vomiting—Methylprednisolone—multiple sclerosis	0.000135	0.00118	CcSEcCtD
Ceftazidime—Rash—Triamcinolone—multiple sclerosis	0.000134	0.00118	CcSEcCtD
Ceftazidime—Dermatitis—Triamcinolone—multiple sclerosis	0.000134	0.00118	CcSEcCtD
Ceftazidime—Rash—Methylprednisolone—multiple sclerosis	0.000134	0.00117	CcSEcCtD
Ceftazidime—Dermatitis—Methylprednisolone—multiple sclerosis	0.000134	0.00117	CcSEcCtD
Ceftazidime—Urticaria—Prednisone—multiple sclerosis	0.000134	0.00117	CcSEcCtD
Ceftazidime—Headache—Triamcinolone—multiple sclerosis	0.000133	0.00117	CcSEcCtD
Ceftazidime—Headache—Methylprednisolone—multiple sclerosis	0.000133	0.00117	CcSEcCtD
Ceftazidime—Abdominal pain—Prednisone—multiple sclerosis	0.000133	0.00117	CcSEcCtD
Ceftazidime—Body temperature increased—Prednisone—multiple sclerosis	0.000133	0.00117	CcSEcCtD
Ceftazidime—Diarrhoea—Betamethasone—multiple sclerosis	0.000132	0.00116	CcSEcCtD
Ceftazidime—Diarrhoea—Dexamethasone—multiple sclerosis	0.000132	0.00116	CcSEcCtD
Ceftazidime—Hypotension—Methotrexate—multiple sclerosis	0.000131	0.00115	CcSEcCtD
Ceftazidime—Dizziness—Betamethasone—multiple sclerosis	0.000128	0.00112	CcSEcCtD
Ceftazidime—Dizziness—Dexamethasone—multiple sclerosis	0.000128	0.00112	CcSEcCtD
Ceftazidime—Nausea—Triamcinolone—multiple sclerosis	0.000126	0.00111	CcSEcCtD
Ceftazidime—Paraesthesia—Methotrexate—multiple sclerosis	0.000126	0.00111	CcSEcCtD
Ceftazidime—Nausea—Methylprednisolone—multiple sclerosis	0.000126	0.00111	CcSEcCtD
Ceftazidime—Hypersensitivity—Prednisone—multiple sclerosis	0.000124	0.00109	CcSEcCtD
Ceftazidime—Vomiting—Betamethasone—multiple sclerosis	0.000123	0.00108	CcSEcCtD
Ceftazidime—Vomiting—Dexamethasone—multiple sclerosis	0.000123	0.00108	CcSEcCtD
Ceftazidime—Rash—Betamethasone—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Ceftazidime—Rash—Dexamethasone—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Ceftazidime—Dermatitis—Betamethasone—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Ceftazidime—Dermatitis—Dexamethasone—multiple sclerosis	0.000122	0.00107	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000121	0.00106	CcSEcCtD
Ceftazidime—Headache—Dexamethasone—multiple sclerosis	0.000121	0.00106	CcSEcCtD
Ceftazidime—Headache—Betamethasone—multiple sclerosis	0.000121	0.00106	CcSEcCtD
Ceftazidime—Pain—Methotrexate—multiple sclerosis	0.00012	0.00105	CcSEcCtD
Ceftazidime—Ceftriaxone—ALB—multiple sclerosis	0.000119	0.0156	CrCbGaD
Ceftazidime—Pruritus—Prednisone—multiple sclerosis	0.000119	0.00104	CcSEcCtD
Ceftazidime—Diarrhoea—Prednisone—multiple sclerosis	0.000115	0.00101	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000115	0.00101	CcSEcCtD
Ceftazidime—Nausea—Betamethasone—multiple sclerosis	0.000115	0.00101	CcSEcCtD
Ceftazidime—Nausea—Dexamethasone—multiple sclerosis	0.000115	0.00101	CcSEcCtD
Ceftazidime—Urticaria—Methotrexate—multiple sclerosis	0.000112	0.00098	CcSEcCtD
Ceftazidime—Dizziness—Prednisone—multiple sclerosis	0.000111	0.000976	CcSEcCtD
Ceftazidime—Abdominal pain—Methotrexate—multiple sclerosis	0.000111	0.000975	CcSEcCtD
Ceftazidime—Body temperature increased—Methotrexate—multiple sclerosis	0.000111	0.000975	CcSEcCtD
Ceftazidime—Vomiting—Prednisone—multiple sclerosis	0.000107	0.000938	CcSEcCtD
Ceftazidime—Rash—Prednisone—multiple sclerosis	0.000106	0.00093	CcSEcCtD
Ceftazidime—Dermatitis—Prednisone—multiple sclerosis	0.000106	0.000929	CcSEcCtD
Ceftazidime—Headache—Prednisone—multiple sclerosis	0.000105	0.000924	CcSEcCtD
Ceftazidime—Cefalotin—ALB—multiple sclerosis	0.000105	0.0136	CrCbGaD
Ceftazidime—Hypersensitivity—Methotrexate—multiple sclerosis	0.000104	0.000909	CcSEcCtD
Ceftazidime—Nausea—Prednisone—multiple sclerosis	9.98e-05	0.000876	CcSEcCtD
Ceftazidime—Pruritus—Methotrexate—multiple sclerosis	9.94e-05	0.000872	CcSEcCtD
Ceftazidime—Diarrhoea—Methotrexate—multiple sclerosis	9.61e-05	0.000844	CcSEcCtD
Ceftazidime—Cephalexin—ALB—multiple sclerosis	9.5e-05	0.0124	CrCbGaD
Ceftazidime—Dizziness—Methotrexate—multiple sclerosis	9.29e-05	0.000815	CcSEcCtD
Ceftazidime—Vomiting—Methotrexate—multiple sclerosis	8.93e-05	0.000784	CcSEcCtD
Ceftazidime—Rash—Methotrexate—multiple sclerosis	8.86e-05	0.000778	CcSEcCtD
Ceftazidime—Dermatitis—Methotrexate—multiple sclerosis	8.85e-05	0.000777	CcSEcCtD
Ceftazidime—Headache—Methotrexate—multiple sclerosis	8.8e-05	0.000773	CcSEcCtD
Ceftazidime—Nausea—Methotrexate—multiple sclerosis	8.34e-05	0.000732	CcSEcCtD
